Top Pharmaceuticals companies in Germany by EBITDA
Germany
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 11.53 B
|
Dec. 31, 2023 | USD 20.20 | -1.60% |
|
Germany |
|
| 2 |
USD 6.27 B
|
Dec. 31, 2023 | USD 145.16 | 0.75% |
|
Germany |
|
| 3 |
USD 4.70 B
|
Sept. 30, 2024 | USD 52.62 | 1.24% |
|
Germany |
|
| 4 |
USD 3.24 B
|
Dec. 31, 2023 | USD 44.66 | 0.37% |
|
Germany |
|
| 5 |
USD 3.02 B
|
Dec. 31, 2023 | USD 35.88 | 1.39% |
|
Germany |
|
| 6 |
USD 1.66 B
|
Dec. 31, 2023 | USD 55.86 | -1.25% |
|
Germany |
|
| 7 |
USD 1.20 B
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
|
| 8 |
USD 975.72 M
|
Dec. 31, 2023 | USD 62.83 | -2.03% |
|
Germany |
|
| 9 |
USD 448.79 M
|
Sept. 30, 2024 | USD 46.27 | -3.11% |
|
Germany |
|
| 10 |
USD 439.64 M
|
Nov. 30, 2023 | USD 67.45 | -0.61% |
|
Germany |
|
| 11 |
USD 293.10 M
|
Dec. 31, 2023 | USD 41.22 | 0.60% |
|
Germany |
|
| 12 |
USD 292.21 M
|
Sept. 30, 2024 | USD 25.13 | -1.97% |
|
Germany |
|
| 13 |
USD 238.23 M
|
Dec. 31, 2023 | USD 22.41 | 0.70% |
|
Germany |
|
| 14 |
USD 197.57 M
|
Dec. 31, 2023 | USD 42.87 | 0.60% |
|
Germany |
|
| 15 |
USD 128.68 M
|
Dec. 31, 2023 | USD 15.25 | 0.60% |
|
Germany |
|
| 16 |
USD 110.23 M
|
Dec. 31, 2023 | USD 2.47 | 0.60% |
|
Germany |
|
| 17 |
USD 90.23 M
|
Dec. 31, 2023 | USD 66.17 | 1.24% |
|
Germany |
|
| 18 |
USD 89.46 M
|
Dec. 31, 2023 | USD 60.50 | -1.24% |
|
Germany |
|
| 19 |
USD 65.86 M
|
Dec. 31, 2023 | USD 48.95 | 1.72% |
|
Germany |
|
| 20 |
USD 58.97 M
|
Dec. 31, 2023 | USD 70.39 | 0.46% |
|
Germany |
|
| 21 |
USD 58.30 M
|
Dec. 31, 2023 | USD 12.64 | -1.48% |
|
Germany |
|
| 22 |
USD 43.95 M
|
Dec. 31, 2023 | USD 29.11 | 3.16% |
|
Germany |
|
| 23 |
USD 39.59 M
|
Dec. 31, 2023 | USD 26.38 | -0.18% |
|
Germany |
|
| 24 |
USD 33.51 M
|
Dec. 31, 2023 | USD 24.32 | -0.24% |
|
Germany |
|
| 25 |
USD 24.05 M
|
Dec. 31, 2023 | USD 15.97 | 3.61% |
|
Germany |
|
| 26 |
USD 8.63 M
|
Dec. 31, 2023 | USD 8.09 | -2.02% |
|
Germany |
|
| 27 |
USD 6.41 M
|
Dec. 31, 2023 | USD 4.18 | 0.60% |
|
Germany |
|
| 28 |
USD 4.62 M
|
Dec. 31, 2023 | USD 3.73 | 0.05% |
|
Germany |
|
| 29 |
USD -2.09 M
|
Sept. 30, 2023 | USD 3.68 | 1.46% |
|
Germany |
|
| 30 |
USD -5.15 M
|
Dec. 31, 2023 | USD 1.49 | -0.76% |
|
Germany |
|
| 31 |
USD -7.86 M
|
Dec. 31, 2023 | USD 4.96 | -2.24% |
|
Germany |
|
| 32 |
USD -14.28 M
|
Dec. 31, 2023 | USD 10.67 | 2.08% |
|
Germany |
|
| 33 |
USD -16.10 M
|
Dec. 31, 2023 | USD 1.09 | 3.54% |
|
Germany |
|
| 34 |
USD -20.36 M
|
Nov. 30, 2023 | USD 2.61 | 0.60% |
|
Germany |
|
| 35 |
USD -24.23 M
|
Dec. 31, 2023 | USD 5.29 | 13.28% |
|
Germany |
|
| 36 |
USD -36.31 M
|
Dec. 31, 2023 | USD 1.33 | -6.34% |
|
Germany |
|
| 37 |
USD -46.43 M
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Germany |
|
| 38 |
USD -98.16 M
|
Dec. 31, 2023 | USD 5.97 | -4.48% |
|
Germany |
|
| 39 |
USD -113.00 M
|
Dec. 31, 2023 | USD 1.07 | -4.46% |
|
Germany |
|
| 40 |
USD -258.38 M
|
Dec. 31, 2023 | USD 3.95 | -0.95% |
|
Germany |
Frequently Asked Questions
-
Which Pharmaceuticals company in Germany has the highest EBITDA ?
The Pharmaceuticals company in Germany with the highest EBITDA is Bayer Aktiengesellschaft (XETRA: BAYN.DE) at USD 11.53 B.
-
Which Pharmaceuticals company in Germany has the lowest EBITDA ?
The Pharmaceuticals company in Germany with the lowest EBITDA is CureVac N.V. (Frankfurt Stock Exchange: 5CV.F) at USD -258.38 M.
-
What are the top 10 Pharmaceuticals companies in Germany by EBITDA ?
The top 10 Pharmaceuticals companies in Germany by EBITDA are Bayer Aktiengesellschaft, MERCK Kommanditgesellschaft auf Aktien, Siemens Healthineers AG, Fresenius Medical Care AG & Co. KGaA, Fresenius SE & Co. KGaA, Brenntag SE, BioNTech SE, Wacker Chemie AG, Carl Zeiss Meditec AG and Gerresheimer AG.
-
What are the bottom 10 Pharmaceuticals companies in Germany by EBITDA ?
The bottom 10 Pharmaceuticals companies in Germany by EBITDA are CureVac N.V., Affimed N.V., Immatics N.V., InflaRx N.V., Atai Life Sciences N.V., Mainz Biomed B.V., Heidelberg Pharma AG, Medigene AG, Apontis Pharma AG and SynBiotic SE.